Home/Search
2025 Fellows Courses
Lunch Program: Optimizing Antiplatelet Therapy in High-Risk PCI
Sponsored by SCAI. Supported by Chiesi.
Introductory Remarks & Pre-Test Questions
Babar B Basir, DO, FSCAI
, Henry Ford Health System, Detroit, MI
View Recording
Download Slides
Case Presentation, Part 1
Adnan Khalif, M.D., FSCAI
, Allegheny Health Network , Pittsburgh, PA
View Recording
Download Slides
Poll: Which Factors Most Influence Your Antiplatelet Selection for STEMI Patients?
Babar B Basir, DO, FSCAI
, Henry Ford Health System, Detroit, MI
View Recording
Download Slides
Pharmacodynamics of Antiplatelet Therapies
Jennifer A Rymer, MD, MBA, MHS
, Duke University Hospital, Chapel Hill, NC
View Recording
Download Slides
Poll: What Is the Primary Clinical Advantage of Cangrelor?
Babar B Basir, DO, FSCAI
, Henry Ford Health System, Detroit, MI
View Recording
Download Slides
Cangrelor in AMI & Cardiogenic Shock
Babar B Basir, DO, FSCAI
, Henry Ford Health System, Detroit, MI
View Recording
Download Slides
Optimal Antiplatelet Strategies in High-Risk Patients
Hayder D. Hashim, M.D., FSCAI
, MedStar Washington Hospital Center, Washington, DC
View Recording
Download Slides
Case Part 2 – Recap and Decision-Making
Adnan Khalif, M.D., FSCAI
, Allegheny Health Network , Pittsburgh, PA
View Recording
Download Slides
Conclusion & Post-Test Question
Babar B Basir, DO, FSCAI
, Henry Ford Health System, Detroit, MI
View Recording
Download Slides
See more of:
Interventional Cardiology Course
<< Previous Session
|
Next Session >>